The Re-Imagination of the IVD Industry Post COVID-19 Report
Countries globally are expected to maintain a test volume exceeding 500,000 subjects per day, with an increasing amount using POCT technology. The volume of testing is expected to be maintained to monitor the outbreak and inform preventative measures.
Investments and innovation in point-of-care diagnostics for infectious diseases and population surveillance will continue. Free drive-through and walk-through testing will lead to an emergence of alternate testing sites, such as pharmacies or ports of entry. Even though flu testing at pharmacies has become common, 2020 will usher in an era where pharmacies offer an unprecedented level of convenience to patients.